(PharmaNewsWire.Com, December 21, 2017 ) Cardiovascular diseases (CVDs) are associated with high mortality rate all over the world. Strokes and heart attacks are two major types of CVD contributing to the growing mortality rate globally. According to the Centers for Disease Control and Prevention (CDC), coronary heart disease (CHD) is the most common type of CVD resulting in heart attack in the US. In the US, about 370,000 people die due to CHD every year. The EP diagnostics and treatment devices such as ablation catheters, pacemakers, and implantable cardioverter defibrillators (ICDs) are used extensively for the CVD treatment.
Publisher's analysts forecast the global electrophysiology devices market to grow at a CAGR of 7.91% during the period 2016-2020.
Covered in this report The report covers the present scenario and the growth prospects of the global electrophysiology devices market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of electrophysiology devices.
The market is divided into the following segments based on geography: -Americas -APAC -EMEA
Publisher's report, Global Electrophysiology Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
